AZTR Azitra
- 0.415
- +0.020+5.01%
- 0.390
- -0.025-6.02%
Azitra News
Promising Prospects for Azitra Inc: Buy Rating Supported by Advancements in ATR-12 and ATR-04 Programs
Azitra 3Q Rev $0.00 >AZTR
Express News | Azitra Q3 Revenue $0 Down From $310.70K YoY
Express News | Anitra Q3 2024 GAAP EPS $(0.17) Beats $(0.41) Estimate
Azitra | 10-Q: Q3 2024 Earnings Report
Express News | Azitra Inc Qtrly Shr Loss $0.17
Express News | Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates
Azitra to Present at BIO-Europe 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit
Buy Rating Justified by Azitra Inc's Advances in Rare Skin Disease Treatments and Financial Stability
Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Express News | Azitra Inc - to Report Interim Safety Data in Early 2025
Maxim Group Maintains Azitra(AZTR.US) With Buy Rating, Maintains Target Price $3
Azitra Inc (AZTR) Receives a Buy From Maxim Group
Express News | Azitra Shares Are Trading Higher After the Company Received FDA Approval to Proceed With Its Phase 1/2 Clinical Study of ATR-04
Azitra Receives Study May Proceed Letter From The FDA For IND To Treat Skin Rash From EGFR Inhibitors
Express News | Azitra Inc - Preclinical Data Show Atr-04 Reduces Il-36Γ and Staphylococcus Aureus
Express News | Azitra Receives Study May Proceed Letter From the FDA for Ind to Treat Skin Rash From Egfr Inhibitors
Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
No Data